Literature DB >> 850603

Erythromycin prophylaxis for pertussis.

W A Altemeir, E M Ayoub.   

Abstract

A neonate admitted to the newborn nursery was found to have bacteriologically proven Bordetella pertussis whooping cough, and two of seven infants exposed to this child became infected. Erythromycin administration to the seven infants apparently prevented further infection as well as the appearance of clinical disease in the two infected infants. This limited experience supports previous reports of the efficacy of erythromycin in preventing B. pertussis infection and disease in susceptible children.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850603

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

Review 1.  Treatment and prevention of pertussis by antimicrobial agents (Part II).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

2.  Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

3.  Whooping cough.

Authors: 
Journal:  Br Med J       Date:  1978-04-22

4.  Whooping cough--a study of severity in hospital cases.

Authors:  D A Robinson; B K Mandal; A G Ironside; E M Dunbar
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

5.  The use of macrolides in respiratory tract infections.

Authors:  J C Pechère
Journal:  Int J Antimicrob Agents       Date:  1993-11       Impact factor: 5.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.